Opus Genetics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +891.1% | +47.5% | +87.9% | +10.1% | -31.7% | +36.3% | |
| – | +902.7% | +47.5% | +87.9% | +10.1% | -32.1% | +36.7% | |
| – | +966.9% | +49.6% | +73.8% | +18.5% | -40.0% | +48.7% | |
| – | +966.9% | +50.9% | +72.4% | +18.4% | -40.0% | +48.7% | |
| – | – | – | – | -51.9% | +147.4% | -45.2% | |
| – | +233.4% | -87.6% | -28.6% | +46.8% | +645.6% | +15.8% | |
| – | -65.9% | +21.0% | -28.6% | +46.8% | +179.4% | -31.1% | |
| – | – | – | – | – | – | – | |
| – | +255.0% | +30.5% | -32.5% | +101.4% | +46.2% | +4.6% | |
| – | – | – | – | – | – | – | |
| – | – | – | +108.1% | +7.9% | -86.5% | +128.3% | |
| – | – | – | – | – | – | – | |
| – | -34.3% | +218.7% | +38.7% | +4.8% | +23.7% | +2,229.1% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.